Koopman Anna G M M, Jenniskens Sjoerd F M, Fütterer Jurgen J
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Top Magn Reson Imaging. 2020 Feb;29(1):47-58. doi: 10.1097/RMR.0000000000000231.
Prostate cancer is the fifth leading cause of death worldwide. A variety of treatment options is available for localized prostate cancer and may range from active surveillance to focal therapy or whole gland treatment, that is, surgery or radiotherapy. Serum prostate-specific antigen levels are an important tool to monitor treatment success after whole gland treatment, unfortunately prostate-specific antigen is unreliable after focal therapy. Multiparametric magnetic resonance imaging of the prostate is rapidly gaining field in the management of prostate cancer and may play a crucial role in the evaluation of recurrent prostate cancer. This article will focus on postprocedural magnetic resonance imaging after different forms of local therapy in patients with prostate cancer.
前列腺癌是全球第五大致死原因。对于局限性前列腺癌，有多种治疗选择，范围可从主动监测到聚焦治疗或全腺治疗，即手术或放疗。血清前列腺特异性抗原水平是监测全腺治疗后治疗效果的重要工具，不幸的是，聚焦治疗后前列腺特异性抗原并不可靠。前列腺多参数磁共振成像在前列腺癌管理领域迅速发展，可能在复发性前列腺癌的评估中发挥关键作用。本文将聚焦于前列腺癌患者接受不同形式局部治疗后的术后磁共振成像。
